Justin Donaca

Chambr is an AI Sales Roleplay and Coaching Platform that helps teams ramp twice as fast, close more deals and build real world selling confidence. Our AI buyers simulate realistic sales conversations across every stage of the revenue cycle: from cold, warm and discovery to renewals and upsells. Reps can practice safely, receive instant feedback and master the art of persuasion before stepping into real conversations. With Chambr, Sales and CS teams can: - Ramp up to 60% faster and onboard new hires in weeks instead of months - Reduce manager coaching time by 1.5 hours/rep/week - Increase rep conversion rates by up to 12% The future of sales enablement isn’t static content anymore. It’s powered by AI and data-driven practice. 🔹 Try our AI bot here: https://chambr.ai/roleplay/jerry 🔹 Book a demo or contact us at alex@chambr.ai

SingleTimeMicroneedles’ mission is to improve community health multiple doses at a time. Our work on multi-dose thermally-stable microneedle patches will increase access to lifesaving veterinary and human pharmaceuticals and supplements. We have developed a drug/vaccine microneedle delivery platform that eliminates the need for cold-chain storage and transportation and are the only patches that can deliver doses immediately, over-time, or separately over weeks/months in one application. The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The APIs are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by 1. eliminating biohazard waste 2. reducing personnel time (one dose, easy application) 3. enabling a high immunogenic efficacy via transdermal delivery 4. increasing patient compliance to dosing schedules 5. eliminate needle sticks for workers Applications include human supplements, animal health products, and human pharmaceuticals.

Medical device company innovating a patent-pending device to provide safety with indwelling urinary catheters.

ALLIANCE OF ANGELS SEED FUND II LLC is an investment banking company based out of 719 SECOND AVE, Seattle, Washington, United States.

Chambr is an AI Sales Roleplay and Coaching Platform that helps teams ramp twice as fast, close more deals and build real world selling confidence. Our AI buyers simulate realistic sales conversations across every stage of the revenue cycle: from cold, warm and discovery to renewals and upsells. Reps can practice safely, receive instant feedback and master the art of persuasion before stepping into real conversations. With Chambr, Sales and CS teams can: - Ramp up to 60% faster and onboard new hires in weeks instead of months - Reduce manager coaching time by 1.5 hours/rep/week - Increase rep conversion rates by up to 12% The future of sales enablement isn’t static content anymore. It’s powered by AI and data-driven practice. 🔹 Try our AI bot here: https://chambr.ai/roleplay/jerry 🔹 Book a demo or contact us at alex@chambr.ai

SingleTimeMicroneedles’ mission is to improve community health multiple doses at a time. Our work on multi-dose thermally-stable microneedle patches will increase access to lifesaving veterinary and human pharmaceuticals and supplements. We have developed a drug/vaccine microneedle delivery platform that eliminates the need for cold-chain storage and transportation and are the only patches that can deliver doses immediately, over-time, or separately over weeks/months in one application. The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The APIs are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by 1. eliminating biohazard waste 2. reducing personnel time (one dose, easy application) 3. enabling a high immunogenic efficacy via transdermal delivery 4. increasing patient compliance to dosing schedules 5. eliminate needle sticks for workers Applications include human supplements, animal health products, and human pharmaceuticals.

Medical device company innovating a patent-pending device to provide safety with indwelling urinary catheters.

ALLIANCE OF ANGELS SEED FUND II LLC is an investment banking company based out of 719 SECOND AVE, Seattle, Washington, United States.

The Golden State Warriors organization is a charter member of the National Basketball Association. Founded in 1946, the Warriors called the city of Philadelphia home for 16 memorable years before moving to the West Coast in 1962 to become the San Francisco Warriors and ultimately, in 1971, the Golden State Warriors when the team moved across the Bay to its home in Oakland, where they stayed for 47 seasons. Now located in San Francisco, the Warriors call Chase Center home. Chase Center, an 18,064-seat sports and entertainment arena, anchors Thrive City, the multipurpose, privately financed complex in San Francisco’s Mission Bay neighborhood consisting of 3.2 acres of publicly accessible plazas and open space that are part of a larger mixed-use development including two office buildings and dozens of unique restaurant and retail locations. The Golden State Warriors have proudly announced the addition of a WNBA franchise coming 2025.